Keyphrases
Primary Care
100%
Type 2 Diabetic Patients
100%
Hemoglobin A1c (HbA1c)
100%
Dapagliflozin
100%
Type 2 Diabetes Mellitus (T2DM)
57%
Insulin
28%
Metformin
28%
Patient Characteristics
14%
Clinical Trials
14%
Routine Care
14%
Primary Care Practice
14%
Inclusion Criteria
14%
Retinopathy
14%
Renal Glucose Reabsorption
14%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
14%
Low Blood Glucose
14%
Baseline HbA1c
14%
Treatment Combination
14%
Nephropathy
14%
Neuropathy
14%
Retrospective Observational Study
14%
Dual Therapy
14%
Clinical Practice Research Datalink
14%
Triple Therapy
14%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Hemoglobin A1c
100%
Primary Health Care
100%
Dapagliflozin
100%
Type 2 Diabetes
50%
Glycon
25%
Clinical Trial
12%
Blood Glucose
12%
Retinopathy
12%
Sodium Glucose Cotransporter 2 Inhibitor
12%
Observational Study
12%
Nephropathy
12%
Neuropathy
12%
Nursing and Health Professions
Primary Medical Care
100%
Non Insulin Dependent Diabetes Mellitus
100%
Hemoglobin A1c
100%
Dapagliflozin
100%
Metformin
25%
Clinical Practice
12%
Glucose Blood Level
12%
Retinopathy
12%
Sodium Glucose Cotransporter 2 Inhibitor
12%
Neuropathy
12%
Kidney Disease
12%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
100%
Hemoglobin A1c
100%
Dapagliflozin
100%
Metformin
25%
Clinical Trial
12%
Retinopathy
12%
Sodium Glucose Cotransporter 2 Inhibitor
12%
Observational Study
12%
Neuropathy
12%
Kidney Disease
12%